Article PDF
Avoid common mistakes on your manuscript.
References
Li, S., Bao, X., Wang, D., You, L., Li, X., Yang, H., Bian, J., Wang, Y., and Yang, Y. (2017). APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells. Sci China Life Sci 60, 617–626.
Su, H., Wang, G., Yuan, R., Wang, J., Tang, Y., Ao, P., and Zhu, X. (2017). Decoding early myelopoiesis from dynamics of core endogenous network. Sci China Life Sci 60, 627–646.
Xie, Z., Liu, H., and Geng, M. (2017). Targeting sphingosine-1-phosphate signaling for cancer therapy. Sci China Life Sci 60, 585–600.
Zhang, Y., Kong, W., and Jiang, J. (2017). Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms. Sci China Life Sci 60, 601–616.
Zheng, B., Zhu, Y., Wang, H.Y., and Chen, L. (2017). Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms. Sci China Life Sci 60, 575–584.
Zhou, X., and Jiang, Z. (2017). STING-Mediated DNA Sensing in Cancer Immunotherapy. Sci China Life Sci 60, 563–574.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. Hong-Yang Wang, a professor, chief physician and doctoral supervisor, currently serves as the director of National Centre for Liver Cancer of China, the director of International Cooperation Laboratory on Signal Transduction in Eastern Hepatobiliary Surgery Hospital, and the chief of Department of Health of the National Natural Science Foundation of China (NSFC). She was selected as a member of Chinese Academy of Engineering in 2005 and as a member of the World Academy of Sciences in 2011. Dr. Hong-Yang Wang received her doctor degree at Ulm University, Germany (1992), and a post-doc training in Molecular Biology at Max-Planck Institute of Biochemistry, in 1995. She pioneered signal transduction research of liver in China. Dr. Hong-Yang Wang has authored more than 200 publications. Additionally, 14 patents of hers have been warranted, including 3 international authorizations. Dr. Hong-Yang Wang’s research focuses on prevention, diagnosis and treatment of liver cancer in China. Her research team is interested in molecular mechanisms and translational medicine research of tumors. They researched and developed the Glypican-3 diagnostic kit to diagnose hepatocellular carcinoma, especially for alpha fetoprotein (AFP)-negative patients. The Kit was approved by China Food and Drug Administration (CFDA) in 2014.
Rights and permissions
About this article
Cite this article
Wang, HY. Non-resolving inflammation and cancer. Sci. China Life Sci. 60, 561–562 (2017). https://doi.org/10.1007/s11427-017-9096-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-017-9096-4